Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 423-425    DOI: 10.31083/j.ceog.2021.02.2128
Case Report Previous articles | Next articles
Should diagnostic hysteroscopy be performed routinely following thermal balloon endometrial ablation? A case report of thermal bowel injury and literature review
Hazem Al-Mandeel1, 2, *()
1Department of Obstetrics and Gynecology, College of Medicine, King Saud University, 999088 Riyadh, Saudi Arabia
2King Saud University Medical City, King Saud University, 999088 Riyadh, Saudi Arabia
Download:  PDF(156KB)  ( 92 ) Full text   ( 17 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Although thermal balloon endometrial ablation (TBEA) is an effective and easy technique, it can cause serious complications, including bowel injury, if perforation occurs. In this paper, a case of thermal bowel injury caused by the Thermablate Endometrial Ablation System is presented with a review of previous literature on such complications. Based on this case and expert recommendations, users are advised to follow established protocols, including hysteroscopy just prior to the insertion of the TBEA catheter to exclude prior uterine perforation from the uterine sound or curettage, and an additional hysteroscopy after completion of the ablation as the final step to ensure that a perforation has not occurred.
Key words:  Menorrhagia      Heavy menstrual bleeding      Endometrial ablation      Thermal balloon ablation      Bowel burn      Bowel injury     
Submitted:  02 May 2020      Revised:  05 July 2020      Accepted:  06 July 2020      Published:  15 April 2021     
*Corresponding Author(s):  Hazem Al-Mandeel     E-mail:  halmandeel@ksu.edu.sa

Cite this article: 

Hazem Al-Mandeel. Should diagnostic hysteroscopy be performed routinely following thermal balloon endometrial ablation? A case report of thermal bowel injury and literature review. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 423-425.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2128     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/423

[1] Anjeza Xholli, Anna Biasioli, Giovanni Grandi, Angelo Cagnacci. Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1186-1192.
[2] Hae Nam Lee, Hui Ryeon Ju, Ji Min Seo, Gi Soo Um, Min Jeong Kim. Clinical factors associated with anxiety and depression in Korean women with abnormal uterine bleeding[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 323-330.
[3] K. Sanuki, K. Nakayama, K. Nakamura, T. Ishibashi, M. Ishikawa, N. Ishikawa, S. Kyo. Rapidly enlarged uterus following microwave endometrial ablation: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 159-160.
[4] Ju-Qi Ma, Chun-Fen Guo, Ayshamgul Hasim. Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 387-390.
[5] K. Nakayama, K. Nakamura, T. Ishibashi, M. Ishikawa, S. Kyo. Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: analysis of its efficacy, recurrence rate, and complications[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 695-699.
[6] M.K. Eken, F. Gungor Ugurlucan, G. Ilhan, E. Çöğendez, B. Devranoğlu, B. Keyif, A. Turfanda. Comparison of office hysteroscopy and dilatation & curettage regarding patient comfort, efficacy and quality of life in patients suffering from menorrhagia: prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 599-604.
[7] M. Nikolaou, G. Androutsopoulos, G. Michail, V. Papadopoulos, G. Adonakis, G. Decavalas. Microwave endometrial ablation after endometrial curettage for the management of heavy menstrual bleeding[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 469-472.
[8] D. Athanatos, G. Pados, C.A. Venetis, P. Stamatopoulos, D. Rousso, D. Tsolakidis, C.P. Stamatopoulos, B.C. Tarlatzis. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(3): 347-351.
[9] T. Senol, I. Kahramanoglu, Y. Dogan, M. Baktiroglu, A. Karateke, N. Suer. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(2): 224-227.
[10] A. Vitagliano, M. Bertin, L. Conte, S. Borgato, C. Leggieri, S. Fagherazzi. Thermal balloon ablation versus transcervical endometrial resection: evaluation of postoperative pelvic pain in women treated for dysfunctional uterine bleeding[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 405-408.
[11] P. Litta, C. Saccardi, L. Tommasi, J. Di Giuseppe, G. Delli Carpini, A. Ciavattini. Risk of recurrent menorrhagia after hydrothermoablation: role of GnRH analogues neoadjuvant treatment in long term successful rate[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 426-431.
[12] K. Nakayama, K. Miyazaki, Y. Kanaoka. Microwave endometrial ablation for hypermenorrhea treatment: a new era in Japan[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(2): 119-120.
[13] K. Nakayama, S. Yeasmin, A. Katagiri, M.T. Rahman, M. Rahman, M. Ishikawa, K. Iida N. Nakayama, S. Aoki, K. Miyazaki. A comparative study between microwave endometrial ablation and conventional surgical procedures for treatment of menorrhagia[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(1): 33-37.
[14] D. Karamanidis, P. Nicolaou, A. Byros, Ger. Koutsougeras. Two-year results of a new two-minute hot liquid balloon endometrial ablation system (Thermablate): a pilot study[J]. Clinical and Experimental Obstetrics & Gynecology, 2009, 36(4): 256-258.
[15] T. Küçük, K. Ertan. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers[J]. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(1): 57-60.
No Suggested Reading articles found!